• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

    4/8/24 5:15:51 AM ET
    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Building Materials
    Industrials
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AEHL alert in real time by email

    Shares of Esperion Therapeutics, Inc. (NASDAQ:ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of NEXLETOL® tablets in diverse populations.

    Esperion Therapeutics shares climbed 7.1% to $3.47 pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Longeveron Inc. (NASDAQ:LGVN) rose 93.2% to $4.25 in pre-market trading after gaining 8% on Friday.
    • Antelope Enterprise Holdings Limited (NASDAQ:AEHL) shares rose 47% to $2.20 in pre-market trading after declining 5% on Friday. On April 1, Antelope Enterprise announced preliminary full year 2023 revenue of $70.4 million.
    • DigiAsia Corp. (NASDAQ:FAAS) shares rose 31.6% to $8.46 in pre-market trading after the jumping around 17% on Friday.
    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) gained 27.2% to $1.31 in pre-market trading.
    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) gained 25.6% to $0.2840 in pre-market trading after dipping over 8% on Friday. The company, last week, announced a 1-for-20 reverse stock split.
    • Auddia Inc. (NASDAQ:AUUD) shares gained 15.4% to $1.65 in pre-market trading after declining around 5% on Friday.
    • Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) rose 15% to $0.39 in pre-market trading. Last week, Galmed Pharmaceuticals filed annual report on Form 20-F for the fiscal year ended Dec. 31, 2023.
    • Destiny Tech100 Inc. (NASDAQ:DXYZ) climbed 10.3% to $65.36 in pre-market trading after jumping around 77% on Friday.
    • MicroStrategy Incorporated (NASDAQ:MSTR) gained 9.4% to $1,573.93 in pre-market trading amid a rise in Bitcoin.


    Losers

    • 22nd Century Group, Inc. (NASDAQ:XXII) declined 22.4% to $2.76 in pre-market trading. 22nd Century Group shares jumped over 140% on Friday after the company signed a new contract manufacturing agreement for the production of branded conventional cigarette products.
    • MediaCo Holding Inc. (NASDAQ:MDIA) fell 18.8% to $3.15 in pre-market trading. Shares of MediaCo Holding jumped 177% on Friday after a 13D amended filing showed Standard General L.P. reported a 95.2% stake in the company as of April 1, 2024.
    • Flora Growth Corp. (NASDAQ:FLGC) fell 15.1% to $2.02 in pre-market trading.
    • Flora Growth, last week, reported the pricing of its underwritten public offering of 1.7 million common shares for aggregate gross proceeds of roughly $3.23 million.
    • ZOOZ Power Ltd. (NASDAQ:ZOOZ) fell 14.5% to $3.50 in pre-market trading.
    • Netcapital Inc. (NASDAQ:NCPL) fell 13.5% to $0.1064 pre-market trading after declining over 6% on Friday.
    •  
    • Globavend Holdings Limited (NASDAQ:GVH) shares fell 11% to $1.46 in pre-market trading after jumping 57% on Friday.
    • CCSC Technology International Holdings Limited (NASDAQ:CCTG) shares fell 8% to $3.11 in pre-market trading after surging around 28% on Friday.
    • BRC Inc. (NYSE:BRCC) shares declined 7.8% to $4.38 in pre-market trading after surging over 5% on Friday.
    • Reliance Global Group, Inc. (NASDAQ:RELI) fell 6.8% to $0.4523 pre-market trading. Reliance Global, last week, reported FY23 earnings.
    • Eupraxia Pharmaceuticals Inc. (NASDAQ:EPRX) fell 5.1% to $2.80 in pre-market trading.


    Now Read This: RADCOM, Lotus Technology And 3 Stocks To Watch Heading Into Monday

    Get the next $AEHL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AEHL
    $ALLR
    $AUUD
    $BCAN

    CompanyDatePrice TargetRatingAnalyst
    Strategy Inc
    $MSTR
    3/10/2026$175.00Buy
    B. Riley Securities
    Strategy Inc
    $MSTR
    1/27/2026$213.00Overweight
    Cantor Fitzgerald
    Esperion Therapeutics Inc.
    $ESPR
    11/25/2025$9.00Overweight
    Piper Sandler
    Strategy Inc
    $MSTR
    11/10/2025Sell → Neutral
    Monness Crespi & Hardt
    Strategy Inc
    $MSTR
    10/15/2025$473.00Buy
    China Renaissance
    Allarity Therapeutics Inc.
    $ALLR
    7/28/2025$9.00Buy
    Ascendiant Capital Markets
    Strategy Inc
    $MSTR
    7/15/2025$175.00 → $200.00Sell
    Monness Crespi & Hardt
    Strategy Inc
    $MSTR
    4/29/2025$480.00Buy
    H.C. Wainwright
    More analyst ratings

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    SEC Filings

    View All

    SEC Form 10-Q filed by Netcapital Inc.

    10-Q - Netcapital Inc. (0001414767) (Filer)

    3/19/26 5:25:32 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    SEC Form NT 10-Q filed by Netcapital Inc.

    NT 10-Q - Netcapital Inc. (0001414767) (Filer)

    3/17/26 5:28:02 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    SEC Form 10-K filed by Longeveron Inc.

    10-K - Longeveron Inc. (0001721484) (Filer)

    3/17/26 4:01:02 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Leng Ami San Man

    3 - Globavend Holdings Ltd (0001978527) (Issuer)

    3/18/26 8:15:24 PM ET
    $GVH
    Integrated Freight & Logistics
    Industrials

    SEC Form 3 filed by new insider Yau Wai Yiu

    3 - Globavend Holdings Ltd (0001978527) (Issuer)

    3/18/26 8:14:22 PM ET
    $GVH
    Integrated Freight & Logistics
    Industrials

    SEC Form 3 filed by new insider Shin Ho Chuen

    3 - Globavend Holdings Ltd (0001978527) (Issuer)

    3/18/26 8:13:43 PM ET
    $GVH
    Integrated Freight & Logistics
    Industrials

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-16) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:30 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLIZET issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLIZET (SUPPL-17) with active ingredient BEMPEDOIC ACID; EZETIMIBE has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211617, Application Classification: Efficacy

    3/25/24 4:41:37 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for NEXLETOL issued to ESPERION THERAPS INC

    Submission status for ESPERION THERAPS INC's drug NEXLETOL (SUPPL-13) with active ingredient BEMPEDOIC ACID has changed to 'Approval' on 03/22/2024. Application Category: NDA, Application Number: 211616, Application Classification: Efficacy

    3/25/24 4:41:29 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Netcapital Reports Third Quarter Fiscal 2026 Financial Results and Provides Corporate Update

    Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW, Netcapital)) (the "Company"), a digital private capital markets ecosystem, today announced financial results and provided corporate highlights for the third quarter of fiscal 2026 ended January 31, 2026. In addition, management plans to host a business update conference call tomorrow, March 20, 2026, at 10:00 a.m. ET. "We completed several key transactions in fiscal Q3 2026," said Rich Wheeless, Netcapital's Chief Executiv

    3/19/26 5:57:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    MediaCo Strengthens Spanish-Language News Strategy with Senior Advisor Alina Falcón

    MediaCo Holding Inc. (NASDAQ:MDIA), today announced the ongoing strategic work of Senior Advisor Alina Falcón with the company's news leadership team as MediaCo continues to strengthen and expand its Spanish-language news operations across television, audio, digital, and streaming platforms. Falcón is one of the most respected leaders in Hispanic media, previously serving as President of News at Univision and Executive Vice President of News at NBCUniversal Telemundo, where she led major national and local news initiatives serving Spanish-speaking audiences across the United States. In her advisory role, Falcón is working with MediaCo's news leadership to enhance editorial strategy and

    3/19/26 12:27:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Auddia Announces LT350 Initiative to Power the Autonomous Vehicle Revolution with Distributed AI Datacenters

    Fulfills critical industry technology void and aligns with global shift toward autonomous mobility Distributed AI datacenters positioned for robotaxi and logistics fleets Data offload + charging in one location BOULDER, Colo., March 19, 2026 (GLOBE NEWSWIRE) -- Auddia Inc. (NASDAQ:AUUD) ("Auddia" or the "Company") today announced a major initiative to position its LT350 platform as the distributed compute backbone for the rapidly scaling autonomous vehicle (AV) industry. LT350, the company redefining AI infrastructure through modular, power-sovereign datacenter canopies, is aligning its platform with the global shift toward autonomous mobility. The announcement follows Nvidia's declara

    3/19/26 6:00:00 AM ET
    $AUUD
    EDP Services
    Technology

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    B. Riley Securities initiated coverage on Strategy Inc with a new price target

    B. Riley Securities initiated coverage of Strategy Inc with a rating of Buy and set a new price target of $175.00

    3/10/26 8:42:16 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Cantor Fitzgerald resumed coverage on Strategy Inc with a new price target

    Cantor Fitzgerald resumed coverage of Strategy Inc with a rating of Overweight and set a new price target of $213.00

    1/27/26 8:49:50 AM ET
    $MSTR
    Computer Software: Prepackaged Software
    Technology

    Piper Sandler initiated coverage on Esperion Therapeutics with a new price target

    Piper Sandler initiated coverage of Esperion Therapeutics with a rating of Overweight and set a new price target of $9.00

    11/25/25 8:41:48 AM ET
    $ESPR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Taslitz Steven bought $223,500 worth of shares (300,000 units at $0.74), increasing direct ownership by 33% to 601,184 units (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    3/9/26 5:08:04 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Director Taslitz Steven bought $129,430 worth of shares (100,000 units at $1.29) (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    11/19/25 4:04:54 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    Director Taslitz Steven bought $128,450 worth of shares (100,000 units at $1.28), increasing direct ownership by 28% to 451,184 units (SEC Form 4)

    4 - BRC Inc. (0001891101) (Issuer)

    11/14/25 4:41:23 PM ET
    $BRCC
    Beverages (Production/Distribution)
    Consumer Staples

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Leadership Updates

    Live Leadership Updates

    View All

    MediaCo Appoints Armando Diaz as Vice President, Operations & Efficiency

    MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Armando Diaz as Vice President, Operations & Efficiency. Diaz will report to Brian Fisher, Chief Revenue Officer of MediaCo. In this role, Diaz will focus on strengthening operational discipline across the organization, simplifying internal processes, and driving sustainable expansion in support of the company's EBITDA growth strategy. Diaz brings more than 20 years of corporate leadership experience, including senior roles within media and broadcast organizations where he has led complex operational environments and cross-functional teams. Throughout his career, he has driven efficiency and transformation initiatives

    3/16/26 8:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    MediaCo Appoints Neida Gotay as Vice President, Integrated Sales

    MediaCo Holding Inc. (NASDAQ:MDIA) today announced the appointment of Neida Gotay as Vice President, Integrated Sales. In this role, Gotay will oversee both local and national sales operations in Orlando and Atlanta, while also leading strategic business development efforts across all Florida markets. She will focus on driving integrated, multi-platform revenue growth, strengthening agency and client partnerships, and ensuring local market execution aligns with MediaCo's expanding national opportunity. Gotay brings deep experience in media sales leadership and revenue strategy, including 18 years at Hearst Television where she played a key role in building and expanding its network of S

    3/13/26 9:00:00 AM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    Sigma Audio Networks, powered by MediaCo, Launches "Alpha Woman" A Bilingual Audio Network Where Her Voice Leads – Women First. Culture Forward.

    Alpha Woman blends contemporary music, culture, and conversation with the voices of relatable personalities, influential women, and cultural tastemakers to create a listening experience that resonates with bilingual, culturally connected women across the United States. Sigma Audio Networks, powered by MediaCo (NASDAQ:MDIA), today announced the launch of Alpha Woman, a new bilingual (English + Spanish) audio network created to celebrate, empower, and connect with the modern multicultural woman. Built around the tagline "Where Her Voice Leads," Alpha Woman delivers a powerful mix of contemporary music, lifestyle programming, cultural conversation, and inspirational voices that reflect the

    3/10/26 2:00:00 PM ET
    $MDIA
    Broadcasting
    Consumer Discretionary

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:02:53 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Flora Growth Corp.

    SC 13D/A - Flora Growth Corp. (0001790169) (Subject)

    12/17/24 8:01:40 PM ET
    $FLGC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $AEHL
    $ALLR
    $AUUD
    $BCAN
    Financials

    Live finance-specific insights

    View All

    Netcapital Reports Third Quarter Fiscal 2026 Financial Results and Provides Corporate Update

    Key milestones include acquisition of Iverson Design and signing PureWave Hydrogen as first tokenization clientManagement to host business update conference call tomorrow at 10:00 am ET BOSTON, MA, March 19, 2026 (GLOBE NEWSWIRE) -- Netcapital Inc. (NASDAQ:NCPL, NCPLW, Netcapital)) (the "Company"), a digital private capital markets ecosystem, today announced financial results and provided corporate highlights for the third quarter of fiscal 2026 ended January 31, 2026. In addition, management plans to host a business update conference call tomorrow, March 20, 2026, at 10:00 a.m. ET. "We completed several key transactions in fiscal Q3 2026," said Rich Wheeless, Netcapital's Chief Executiv

    3/19/26 5:57:00 PM ET
    $NCPL
    Finance: Consumer Services
    Finance

    Longeveron Announces 2025 Full Year Financial Results and Provides Business Update

    On track for third quarter 2026 top-line trial results from anticipated pivotal Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for HLHS, a rare pediatric disease and orphan-designated indicationELPIS II may serve as foundation for a Biologics License Application (BLA) submission for full approval for HLHS, if results demonstrate sufficient evidence of efficacyClosed a private placement of up to $30 million, with $15 million funded in the initial closing, led by Coastlands Capital with participation from Janus Henderson Investors and other healthcare focused fundsCompany to host conference call and webcast today at 4:30 p.m. ET MIAMI, March 17

    3/17/26 4:05:00 PM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026

    MIAMI, March 12, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today announced that it will report 2025 full year financial results and provide a business update on Tuesday, March 17, 2026 after the U.S. financial markets close. The Company will host a conference call and webcast the same day at 4:30 p.m. ET. Conference Call and Webcast Details: Conference Call Number:1.877.407.0789Conference ID:13758462  Call meTM Feature:Click HereWebcast:Click Here   An archived replay of the webcast will be available on the "Events & Presentations" sec

    3/12/26 9:00:00 AM ET
    $LGVN
    Biotechnology: Pharmaceutical Preparations
    Health Care